secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001641172-25-022978
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros Q2 net rev $4.4M (+36% YoY); net income $237k vs loss $289k; 3rd consecutive profitable quarter
--------------------------------------------------------------------------------

- Net revenue $4.4M, up 36% YoY from $3.3M; net income $237k vs net loss $289k.
- Adjusted EBITDA $355k vs $(133k); gross margin improved to 63% from 59%.
- Six-month net income $795k vs loss $458k; revenue $9.3M (+37% YoY).
- Programmatic sales all-time high; largest dialysis filtration PO in company history.
- Cash $5.1M, debt-free; active-site counts at all-time highs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000164117225022978/0001641172-25-022978-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000164117225022978/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-022978

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer